| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 5e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 2e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.096 | 0.09 |